Latest filing published 31 Jul 2026 for DBV Technologies S.A., €1,100.
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Pharis Mohideen has filed trades across 2 companies (mainly through SEC (Form 4)), most often in DBV Technologies S.A. and Tempest Therapeutics, Inc. Between 7 December 2018 and 29 July 2026, the trades on record add up to 23 filings.
On the market, this insider has only sold: 16 sales, €40k in total. The rest of the record consists of 7 share grants. In 2026 alone, the filings show no purchases and 2 sales.
The record was last updated on 31 July 2026 with an open-market sale (€1,100) in DBV Technologies S.A. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 of 14 declarations